Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277